VAVELTA® — the story so far

VAVELTA® is a skin rejuvenation product intended to improve structure, function and appearance of skin. VAVELTA® is a suspension of human dermal fibroblasts (HDFs) in cell storage medium, for injection into the skin. Fibroblasts are responsible for the production of collagen and, when injected into the skin, they are intended to produce collagen.

VAVELTA® is being used by a limited number of physicians in the UK. If you are a physician, interested in providing VAVELTA® to your patients, please complete and return this contact form. 

Intercytex Group plc is a publicly quoted British company that develops innovative cell therapy products for the regeneration and repair of skin and hair.

The composition of VAVELTA® and its use in manufacturing products for cosmetic treatments is protected under UK patent law, patent no. GB 2426452B, entitled "Tissue repair".